That's the famous "arc to Arcturus" star-hop. Rising in the east-northeast will be Vega. Now look between Arcturus and Vega (slightly closer to Arcturus) for a faint curl of seven stars — Corona ...

Venus has just left the evening sky, and now Jupiter and Saturn are moving in. By mid-month both will be up in the southeast before midnight. Jupiter, by far the brighter planet, shines west of ...

The Arcturus subvariant stems from the Omicron strain of Covid-19 and is known as XBB.1.16 since it descends from the recombinant variant XBB, which combines two sublineages of Omicron BA.2.

Neda Safarzadeh, Sr. Director, Head of IR, PR & Marketing, Arcturus Therapeutics Holdings Inc., San Diego, CA, USA, Tel: +1-858-900-2682 Arcturus Therapeutics, based ...

As August begins, Jupiter comes out in the sun’s afterglow and soon drops out of sight. High in the southwest, the brilliant star Arcturus starts a month-long plummet to the horizon, ...

Arcturus is advancing its vaccine and rare disease pipeline with significant developments. The initiation of a BARDA-funded Phase 1 study for bird flu, along with ongoing studies in cystic ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcturus Therapeutics ARCT in the last three months. The table below summarizes their recent ...

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report), with a price target of $63.00. Discover outperforming stocks ...

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy recommendation. As of December 23, 2024, the average one-year price ...